John Ashby - Concepedia

Author

John Ashby

AstraZeneca (United Kingdom)

Also Known As

J P Ashby, J Peter Ashby, J.P. Ashby, J.Peter Ashby, JOHN ASHBY, John A Ashby, John ASHBY, John Ashby

234

Publications

7.8K

Citations

H-Index

143

Concepts

All Affiliations

AstraZeneca (United Kingdom)Syngenta (United Kingdom)Research Triangle Park Foundation Indiana University Bloomington

About

John Ashby is an author at AstraZeneca (United Kingdom) specializing in medicine, toxicology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	32	61	4K
2	Public Health	14	16	731
3	Engineering	11	11	608
4	Natural Sciences	11	12	377
5	Health Sciences	5	5	219

John Ashby

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Some Alkyl Hydroxy Benzoate Preservatives (Parabens) Are Estrogenic Edwin J. Routledge, Joanne Parker, J. Odum, Toxicology and Applied Pharmacology Endocrine DisruptorsHormonal ContraceptiveGynecologyOrganic ChemistrySteroid Metabolism	1998	713
Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP John Ashby, Raymond W. Tennant Mutation Research/Reviews in Genetic Toxicology Chemical SafetyDefinitive RelationshipsMedicineChemical HazardU.s. Ntp	1991	681
Evaluation of six short term tests for detecting organic chemical carcinogens and recommendations for their use I. F. H. Purchase, E. Longstaff, John Ashby, Nature Occupational ToxicologyEnvironmental ChemistryEngineeringShort Term TestsMedicine	1976	277
Lack of Effects for Low Dose Levels of Bisphenol A and Diethylstilbestrol on the Prostate Gland of CF1 Mice Exposed in Utero John Ashby, H. Tinwell, J HASEMAN Regulatory Toxicology and Pharmacology Endocrine DisruptorsUrologyMedicineHormonal ReceptorProstate Gland	1999	233
Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 39 chemicals tested for carcinogenicity by the U.S. National Toxicology Program Raymond W. Tennant, John Ashby Mutation Research/Reviews in Genetic Toxicology Further 39Chemical HazardPathologyToxicology TestingToxicology	1991	226
Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity John Ashby Environmental Mutagenesis Oncogenic AgentMolecular BiologyToxicologyPotential CarcinogenicityMedicine	1985	183
The prospects for a simplified and internationally harmonized approach to the detection of possible human carcinogens and mutagens John Ashby Mutagenesis Possible Human CarcinogensEngineeringImmunologyPathologyToxicology Testing	1986	151
The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Jun Kanno, Lesley Onyon, Shyamal D. Peddada, Environmental Health Perspectives Hormonal ContraceptiveFertilityReproductive HealthFemale Reproductive FunctionExperimental Pharmacology	2003	139
Does carcinogenic potency correlate with mutagenic potency in the Ames assay? John Ashby, J.A. Styles Nature Oncogenic AgentMedicinePharmacologyPathologyMutagenic Potency	1978	135
A protocol and guide for the in vitro rat hepatocyte DNA-repair assay Byron E. Butterworth, John Ashby, Edilberto Bermudez, Mutation Research/Genetic Toxicology HepatologyNatural SciencesLiver PhysiologyHistopathologyPathology	1987	119

Page 1